Cytotoxicity against sensitive human KYSE-510 cells after 72 hrs by MTT assay, IC50=2.96μM
23252603
KYSE-510
Cytotoxicity assay
72 hrs
Cytotoxicity against resistant human KYSE-510 cells after 72 hrs by MTT assay, IC50=2.48μM
23252603
CAL27
Cytotoxicity assay
72 hrs
Cytotoxicity against resistant human CAL27 cells after 72 hrs by MTT assay, IC50=1.81μM
23252603
MDA-MB-231
Cytotoxicity assay
72 hrs
Cytotoxicity against resistant human MDA-MB-231 cells after 72 hrs by MTT assay, IC50=1.68μM
23252603
MDA-MB-231
Cytotoxicity assay
72 hrs
Cytotoxicity against sensitive human MDA-MB-231 cells after 72 hrs by MTT assay, IC50=1.37μM
23252603
CAL27
Cytotoxicity assay
72 hrs
Cytotoxicity against sensitive human CAL27 cells after 72 hrs by MTT assay, IC50=1.03μM
23252603
KYSE-510
Function assay
18 hrs
Inhibition of HDAC in sensitive human KYSE-510 cells after 18 hrs by fluorescence assay, IC50=1μM
23252603
A2780
Function assay
18 hrs
Inhibition of HDAC in human A2780 cells after 18 hrs by fluorescence assay, IC50=0.65μM
23252603
A2780
Cytotoxicity assay
72 hrs
Cytotoxicity against human A2780 cells after 72 hrs by MTT assay, IC50=0.49μM
23252603
DLD1
Function assay
1 to 10 uM
24 hrs
Inhibition of VPS34 in human DLD1 cells assessed as prevention of FTH1 protein degradation at 1 to 10 uM incubated for 24 hrs by Western blot analysis
23252603
DLD1
Function assay
1 to 10 uM
24 hrs
Inhibition of VPS34 in human DLD1 cells assessed as prevention of NDP52 protein degradation at 1 to 10 uM incubated for 24 hrs by Western blot analysis
23252603
DLD1
Function assay
1 to 10 uM
24 hrs
Inhibition of VPS34 in human DLD1 cells assessed as prevention of NBR1 protein degradation at 1 to 10 uM incubated for 24 hrs by Western blot analysis
23252603
A2780
Cytotoxicity assay
72 hrs
Cytotoxicity against resistant human A2780 cells after 72 hrs by MTT assay, IC50=0.32μM
23252603
A2780
Function assay
18 hrs
Inhibition of HDAC in resistant human A2780 cells after 18 hrs by fluorescence assay, IC50=0.32μM
23252603
DLD1
Function assay
1 to 10 uM
24 hrs
Inhibition of VPS34 in human DLD1 cells assessed as prevention of NCOA4 protein degradation at 1 to 10 uM incubated for 24 hrs by Western blot analysis
23252603
HepG2
Antimalarial assay
48 hrs
Antimalarial activity against exo-erythrocytic form of Plasmodium berghei infected in human HepG2 cells after 48 hrs, IC50=0.16μM
24904967
DLD1
Function assay
1 to 10 uM
24 hrs
Inhibition of VPS34 in human DLD1 cells assessed as prevention of p62 degradation at 1 to 10 uM incubated for 24 hrs by Western blot analysis
23252603
HepG2
Cytotoxicity assay
48 hrs
Cytotoxicity against human HepG2 cells after 48 hrs, IC50=1.26μM